These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 10795369

  • 1. Familial defective apolipoprotein B-100 (R3500Q) in Northern Ireland.
    McClean E, Graham CA, Ward AJ, Young IS, Martin S, Nicholls DP.
    Br J Biomed Sci; 1999; 56(4):258-62. PubMed ID: 10795369
    [Abstract] [Full Text] [Related]

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK.
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [Abstract] [Full Text] [Related]

  • 3. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
    Defesche JC, Pricker KL, Hayden MR, van der Ende BE, Kastelein JJ.
    Arch Intern Med; 1993 Oct 25; 153(20):2349-56. PubMed ID: 8215738
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M, Hapizah MN, Khalid BA, Khalid Y, Rosli A, Jamal R.
    Malays J Pathol; 2006 Jun 25; 28(1):7-15. PubMed ID: 17694954
    [Abstract] [Full Text] [Related]

  • 6. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
    Dedoussis GV, Skoumas J, Pitsavos C, Choumerianou DM, Genschel J, Schmidt H, Stefanadis C.
    Eur J Clin Invest; 2004 Jun 25; 34(6):402-9. PubMed ID: 15200491
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic causes of familial hypercholesterolaemia in a Malaysian population.
    Khoo KL, Van Acker P, Tan H, Deslypere JP.
    Med J Malaysia; 2000 Dec 25; 55(4):409-18. PubMed ID: 11221151
    [Abstract] [Full Text] [Related]

  • 9. Familial defective apolipoprotein B-100: molecular basis, prevalence and clinical features.
    Friedl W.
    Wien Klin Wochenschr; 1991 Dec 25; 103(20):621-5. PubMed ID: 1763509
    [Abstract] [Full Text] [Related]

  • 10. Familial ligand-defective apolipoprotein B-100: simultaneous detection of the ARG3500-->GLN and ARG3531-->CYS mutations in a French population.
    Rabès JP, Varret M, Saint-Jore B, Erlich D, Jondeau G, Krempf M, Giraudet P, Junien C, Boileau C.
    Hum Mutat; 1997 Dec 25; 10(2):160-3. PubMed ID: 9259199
    [Abstract] [Full Text] [Related]

  • 11. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
    Real JT, Chaves FJ, Ejarque I, García-García AB, Valldecabres C, Ascaso JF, Armengod ME, Carmena R.
    Eur J Hum Genet; 2003 Dec 25; 11(12):959-65. PubMed ID: 14508510
    [Abstract] [Full Text] [Related]

  • 12. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.
    Myant NB.
    Atherosclerosis; 1993 Dec 25; 104(1-2):1-18. PubMed ID: 8141833
    [Abstract] [Full Text] [Related]

  • 13. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW, Defesche JC, Kastelein JJ, Sijbrands EJ.
    Semin Vasc Med; 2004 Aug 25; 4(3):259-64. PubMed ID: 15630635
    [Abstract] [Full Text] [Related]

  • 14. [Familial defect of apo B-100 in subjects with clinically diagnosed primary hypercholesterolemia: identification of the first family with this disorder in Spain].
    Real JT, Chaves JF, Ascaso JF, Armengod ME, Carmena R.
    Med Clin (Barc); 1999 Jun 12; 113(1):15-7. PubMed ID: 10422071
    [Abstract] [Full Text] [Related]

  • 15. [Identification and characterization of the first Spanish familial ligand-defective apolipoprotein B homozygote].
    Ejarque I, Civer M, Francisco Ascaso J, Knecht E, Eugenia Armengod M, Carmen R, Tomás Real J, Francisco Chaves J, Javier Martín De Llano J.
    Med Clin (Barc); 2001 Feb 03; 116(4):138-41. PubMed ID: 11222161
    [Abstract] [Full Text] [Related]

  • 16. [Screening for mutations in apolipoprotein B genes in a group of patients with hyperlipoproteinemia].
    Grombiríková H, Freiberger T, Kuhrová V, Soska V, Nedomová K.
    Cas Lek Cesk; 2001 Jan 19; 140(1):18-21. PubMed ID: 11242979
    [Abstract] [Full Text] [Related]

  • 17. Familial ligand-defective apolipoprotein B-100: detection, biochemical features and haplotype analysis of the R3531C mutation in the UK.
    Wenham PR, Henderson BG, Penney MD, Ashby JP, Rae PW, Walker SW.
    Atherosclerosis; 1997 Mar 21; 129(2):185-92. PubMed ID: 9105560
    [Abstract] [Full Text] [Related]

  • 18. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Pimstone SN, Defesche JC, Clee SM, Bakker HD, Hayden MR, Kastelein JJ.
    Arterioscler Thromb Vasc Biol; 1997 May 21; 17(5):826-33. PubMed ID: 9157944
    [Abstract] [Full Text] [Related]

  • 19. Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB.
    van der Hoek YY, Lingenhel A, Kraft HG, Defesche JC, Kastelein JJ, Utermann G.
    J Clin Invest; 1997 May 01; 99(9):2269-73. PubMed ID: 9151801
    [Abstract] [Full Text] [Related]

  • 20. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
    Raal FJ, Pilcher G, Rubinsztein DC, Lingenhel A, Utermann G.
    Atherosclerosis; 1997 Feb 28; 129(1):97-102. PubMed ID: 9069523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.